Pediatric Infuvite Multiple Vitamins (Ascorbic Acid, Vitamin A Palmitate, Cholecalciferol, Thiamine Hydrochloride, Riboflavin-5 Phosphate Sodium, Pyridoxine Hydrochloride, Niacinamide, Dexpanthenol, Alpha-Tocopherol Acetate, Vitamin K1, Folic Acid, Biotin, Cyanocobalamin) Drug Interactions

Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.

A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Pediatric Infuvite Multiple Vitamins. Always confirm against the full prescribing information.

100 interactions

Abemaciclib

Abemaciclib may decrease the excretion rate of Folic acid which could result in a higher serum level.

Level 2 evidence

Acebutolol

The metabolism of Acebutolol can be decreased when combined with Cholecalciferol.

Level 1 evidence

Acetaminophen

The metabolism of Acetaminophen can be decreased when combined with Cholecalciferol.

Level 1 evidence

Acitretin

The risk or severity of adverse effects can be increased when Vitamin A is combined with Acitretin.

Level 1 evidence

Acyclovir

The risk or severity of adverse effects can be increased when Acyclovir is combined with Thiamine.

Level 2 evidence

Afatinib

Afatinib may decrease the excretion rate of Folic acid which could result in a higher serum level.

Level 2 evidence

Aldesleukin

The therapeutic efficacy of Cyanocobalamin can be decreased when used in combination with Aldesleukin.

Level 1 evidence

Alectinib

Alectinib may decrease the excretion rate of Folic acid which could result in a higher serum level.

Level 2 evidence

Alemtuzumab

The therapeutic efficacy of Cyanocobalamin can be decreased when used in combination with Alemtuzumab.

Level 1 evidence

Alitretinoin

The risk or severity of adverse effects can be increased when Vitamin A is combined with Alitretinoin.

Level 1 evidence

Abacavir

Cyanocobalamin may decrease the excretion rate of Abacavir which could result in a higher serum level.

Level 2 evidence

Abacavir

Pyridoxine may decrease the excretion rate of Abacavir which could result in a higher serum level.

Level 2 evidence

Abacavir

Phylloquinone may decrease the excretion rate of Abacavir which could result in a higher serum level.

Level 2 evidence

Abacavir

Abacavir may increase the hepatotoxic activities of Vitamin A.

Level 2 evidence

Abacavir

Abacavir may decrease the excretion rate of Dexpanthenol which could result in a higher serum level.

Level 2 evidence

Abacavir

Folic acid may decrease the excretion rate of Abacavir which could result in a higher serum level.

Level 2 evidence

Enter your NPI to unlock 2 major interactions for Pediatric Infuvite Multiple Vitamins

I don't know my NPI#

More tools for Pediatric Infuvite Multiple Vitamins

Check coverage & formularyVerify PA requirements for your patient's plan.Prior authorization formsDownload PA forms and appeal templates.Find savings programsCopay cards, patient assistance, and more.

Frequently Asked Questions (FAQ)